The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers

Journal of Managed Care & Specialty Pharmacy
Satya SurbhiJames E Bailey

Abstract

Nonadherence to essential chronic medications has been identified as a potential driver of high health care costs in superutilizers of inpatient services. Few studies, however, have documented the levels of nonadherence and factors associated with nonadherence in this high-cost, vulnerable population. To examine the factors associated with nonadherence to essential chronic medications, with special emphasis on mental illness and use of opioid medications. This study was a retrospective panel analysis of 2-year baseline data for Medicare Part D beneficiaries eligible for the SafeMed care transitions program in Memphis, Tennessee, from February 2013 to December 2014. The 2-year baseline data for each patient were divided into four, 6-month patient periods. The study included Medicare superutilizers (defined as patients with ≥ 3 hospitalizations or ≥ 2 hospitalizations with ≥ 2 emergency visits in 6 months) with continuous Part D coverage who had filled at least 1 drug class used to treat hypertension, diabetes mellitus, congestive heart failure, coronary artery disease, or chronic lung disease. The outcome included medication nonadherence assessed using proportion of days covered (PDC), with PDC < 80% defined as nonadherent, and ...Continue Reading

References

Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Apr 28, 2004·Diabetes Care·Joyce A Cramer
Jan 25, 2005·Health Services Research·Andrew B BindmanPeter Bacchetti
Apr 29, 2005·Journal of General Internal Medicine·Alan J ForsterDavid W Bates
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
May 25, 2005·Archives of Internal Medicine·Richard H ChapmanJ Sanford Schwartz
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Sep 15, 2005·Archives of Internal Medicine·Eric A ColemanSung-joon Min
Mar 15, 2006·Archives of Internal Medicine·Jeffrey L SchnipperDavid W Bates
Jun 2, 2006·The New England Journal of Medicine·John HsuJoseph V Selby
Aug 11, 2006·Journal of General Internal Medicine·Ian M KronishKarina W Davidson
Sep 27, 2006·Archives of Internal Medicine·P Michael HoJohn S Rumsfeld
Nov 16, 2006·Journal of General Internal Medicine·Julie A GazmararianKimberly Rask
May 9, 2007·Health Affairs·Gerald F Riley
Nov 11, 2008·International Journal of Chronic Obstructive Pulmonary Disease·Ruben D RestrepoRobert L Wilkins
Dec 17, 2008·Annals of Internal Medicine·Andrew B BindmanGlenna M Auerback
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
Jun 17, 2009·Circulation·P Michael HoJohn S Rumsfeld
Jan 7, 2011·Health Affairs·M Christopher RoebuckTroyen A Brennan
Feb 18, 2011·JAMA : the Journal of the American Medical Association·Joshua J Gagne, Niteesh K Choudhry
Mar 11, 2011·Mayo Clinic Proceedings·Marie T Brown, Jennifer K Bussell
Aug 2, 2011·Public Health Reports·Anand K ParekhUNKNOWN HHS Interagency Workgroup on Multiple Chronic Conditions
Mar 16, 2012·JAMA : the Journal of the American Medical Association·Donald M Berwick, Andrew D Hackbarth
Aug 14, 2012·The American Journal of the Medical Sciences·James E BaileyJim Y Wan
Feb 25, 2014·Medical Care·Elsie FreemanDeborah A Thayer
Oct 17, 2015·The Journal of Emergency Medicine·L Jeff HarrisJames E Bailey
Oct 11, 2016·Journal of the American Pharmacists Association : JAPhA·Satya SurbhiJames E Bailey
May 4, 2017·Patient Preference and Adherence·Olga Z RosenJoshua M Pevnick

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.